Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis
- Author
- NISHIDA, K1 ; KANEKO, T1 ; KONDO, M4 ; YONEDA, M1 ; NAKAGAWA, S1 ; ISHIKAWA, T1 ; YAMANE, E2 ; NISHIOKA, B2 ; MIYAMOTO, Y3 ; TAKANO, H4 ; YOSHIKAWA, T4
[1] Gastroenterology, Shakaihoken Kobe Central Hospital, Kobe, Japan
[2] Surgery, Shakaihoken Kobe Central Hospital, Kobe, Japan
[3] Radiology, Shakaihoken Kobe Central Hospital, Kobe, Japan
[4] First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan - Source
Journal of surgical oncology. 1999, Vol 71, Num 3, pp 140-146 ; ref : 27 ref
- CODEN
- JSONAU
- ISSN
- 0022-4790
- Scientific domain
- Medical oncology
- Publisher
- Wiley-Liss, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antigène CA 19 9 Classification par stade Corrélation Evaluation Forme clinique Homme Marqueur tumoral Pancréas Pronostic Temps doublement Tumeur maligne Appareil digestif pathologie Pancréas pathologie
- Keyword (en)
- Antigen CA 19 9 Stage classification Correlation Evaluation Clinical form Human Tumoral marker Pancreas Prognosis Doubling time Malignant tumor Digestive diseases Pancreatic disease
- Keyword (es)
- Antígeno CA 19 9 Clasificación por etapas Correlación Evaluación Forma clínica Hombre Marcador tumoral Páncreas Pronóstico Tiempo duplicación Tumor maligno Aparato digestivo patología Páncreas patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13C Liver. Biliary tract. Portal circulation. Exocrine pancreas / 002B13C01 Tumors
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1907323
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/(SICI)1096-9098(199907)71:3<140::AID-JSO2>3.0.CO;2-T 
https://dx.doi.org/10.1002/(SICI)1096-9098(199907)71:3<140::AID-JSO2>3.0.CO;2-T
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:60:\"10.1002\/(SICI)1096-9098(199907)71:3<140::AID-JSO2>3.0.CO;2-T\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of surgical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. surg. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"71\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"140\";s:8:\"\u0000*\u0000epage\";s:3:\"146\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-4790\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NISHIDA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:9:\"KANEKO, T\";i:1;s:8:\"KONDO, M\";i:2;s:9:\"YONEDA, M\";i:3;s:11:\"NAKAGAWA, S\";i:4;s:11:\"ISHIKAWA, T\";i:5;s:9:\"YAMANE, E\";i:6;s:11:\"NISHIOKA, B\";i:7;s:11:\"MIYAMOTO, Y\";i:8;s:9:\"TAKANO, H\";i:9;s:12:\"YOSHIKAWA, T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JSONAU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:60:\"10.1002\/(SICI)1096-9098(199907)71:3<140::AID-JSO2>3.0.CO;2-T\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of surgical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. surg. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"71\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"140\";s:8:\"\u0000*\u0000epage\";s:3:\"146\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-4790\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NISHIDA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:9:\"KANEKO, T\";i:1;s:8:\"KONDO, M\";i:2;s:9:\"YONEDA, M\";i:3;s:11:\"NAKAGAWA, S\";i:4;s:11:\"ISHIKAWA, T\";i:5;s:9:\"YAMANE, E\";i:6;s:11:\"NISHIOKA, B\";i:7;s:11:\"MIYAMOTO, Y\";i:8;s:9:\"TAKANO, H\";i:9;s:12:\"YOSHIKAWA, T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JSONAU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:60:\"10.1002\/(SICI)1096-9098(199907)71:3<140::AID-JSO2>3.0.CO;2-T\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:60:\"10.1002\/(SICI)1096-9098(199907)71:3<140::AID-JSO2>3.0.CO;2-T\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of surgical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. surg. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"71\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"140\";s:8:\"\u0000*\u0000epage\";s:3:\"146\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-4790\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NISHIDA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:9:\"KANEKO, T\";i:1;s:8:\"KONDO, M\";i:2;s:9:\"YONEDA, M\";i:3;s:11:\"NAKAGAWA, S\";i:4;s:11:\"ISHIKAWA, T\";i:5;s:9:\"YAMANE, E\";i:6;s:11:\"NISHIOKA, B\";i:7;s:11:\"MIYAMOTO, Y\";i:8;s:9:\"TAKANO, H\";i:9;s:12:\"YOSHIKAWA, T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JSONAU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:60:\"10.1002\/(SICI)1096-9098(199907)71:3<140::AID-JSO2>3.0.CO;2-T\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of surgical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. surg. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"71\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"140\";s:8:\"\u0000*\u0000epage\";s:3:\"146\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-4790\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NISHIDA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:9:\"KANEKO, T\";i:1;s:8:\"KONDO, M\";i:2;s:9:\"YONEDA, M\";i:3;s:11:\"NAKAGAWA, S\";i:4;s:11:\"ISHIKAWA, T\";i:5;s:9:\"YAMANE, E\";i:6;s:11:\"NISHIOKA, B\";i:7;s:11:\"MIYAMOTO, Y\";i:8;s:9:\"TAKANO, H\";i:9;s:12:\"YOSHIKAWA, T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JSONAU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:60:\"10.1002\/(SICI)1096-9098(199907)71:3<140::AID-JSO2>3.0.CO;2-T\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of surgical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. surg. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"71\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"140\";s:8:\"\u0000*\u0000epage\";s:3:\"146\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-4790\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NISHIDA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:9:\"KANEKO, T\";i:1;s:8:\"KONDO, M\";i:2;s:9:\"YONEDA, M\";i:3;s:11:\"NAKAGAWA, S\";i:4;s:11:\"ISHIKAWA, T\";i:5;s:9:\"YAMANE, E\";i:6;s:11:\"NISHIOKA, B\";i:7;s:11:\"MIYAMOTO, Y\";i:8;s:9:\"TAKANO, H\";i:9;s:12:\"YOSHIKAWA, T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JSONAU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:135:\"Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
